Eutilex

Developing T cell-based therapeutics and antibodies for the treatment of cancer.

placeSeoul, Seoul, South Korea calendar_todayFounded 2015 groups103 employees language eutilex.com

Innovation

41 patent families (14 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 2,306 times.

YearFilings
20172
20186
20196
202014
202113
202222
202311
202416
202510
20261

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital571%
Private equity114%
Other / undisclosed114%
Coming soon